Phase I Study Trends and Market Outlook 2018-2022 - ResearchAndMarkets.com

DUBLIN--()--The "Phase I Study Trends and Market Outlook (2018-2022)" report has been added to ResearchAndMarkets.com's offering.

Keeping up-to-date with the evolving pharmaceutical market is no easy task. The constant flow of newsletters hitting our inboxes is almost too much to wade through. But stay abreast of the market we must.

For this report, 143 Phase I decision-makers were surveyed to share their insights into where the Phase I market is now and where it's expected to head over the next four years. Phase I Study Trends and Market Outlook.

What you will learn:

  • 4-year examination of the industry's Phase I market dynamics (e.g. study volume, outsourced spend)
  • Average dollar value of outsourced Phase I studies and how this varies by sponsor size
  • How large, mid-size, Phase I specialists, and AMCs are selected for patient vs. healthy volunteer studies and what proportion of Phase I spend goes to each provider type
  • How trends are evolving in the Phase I market (e.g. expanse into developing markets, evolving study complexity, and use of methods such as Real-World Evidence, patient centricity, non-traditional monitoring, ePRO, sensors/patches, and activity trackers, etc.)

How you can use this report:

  • Build your sales, marketing, and strategic plans using dependable industry figures
  • Ensure your Phase I outsourcing practices are industry-standard or better

For Pharma:

  • Use the predictions of your peers to identify in what types of studies your competition is investing resources and understand how your company's strategy compares to that of the industry.

For CROs:

  • Utilize this information to ensure your capabilities and capacity are in line with the study types and volume that will be needed in the near future.

Major Topics:

Executive Summary:

  • Market Dynamics
  • Provider Selection
  • Trends and Predictions

Study Data:

  • Phase I Study Volume and Design
  • Phase I Outsourcing Practices
  • Provider Perceptions and Selection
  • Trends and Predictions

For more information about this report visit https://www.researchandmarkets.com/r/7j4z1a

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Clinical Trials

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Clinical Trials